Biospectrumindia

A research team from Pohang University of Science and Technology (POSTECH), in , has engineered an artificial kidney that allows for the early detection of adverse drug reactions.

Korea designs artificial kidney for early detection of drug toxicity Korea designs artificial kidney for early detection of drug toxicity

Roche Diagnostics India, Neighbouring Markets has partnered with the CAHO- Consortium of Accredited Health care Organisation (CAHO) to redefine laboratory practices in by initiating a benchmarking study and conducting an programme for laboratories in the country.

Roche Diagnostics India and CAHO launch benchmarking survey for laboratory practice Offers tools that compare current lab practices using peer-to-peer benchmarking for continuous improvement and upskilling

Mumbai-based Sahajanand Medical Technologies (SMT) has been selected as the exclusive distributor of US-based Penumbra’s peripheral and coronary vascular thrombectomy technologies in select domestic geographies in India.

Penumbra picks SMT as exclusive distributor for thrombectomy technologies in India For Penumbra’s latest mechanical and computer-aided aspiration technology in India

Dr Ashutosh Raghuvanshi , Managing Director and CEO, Fortis Healthcare has been announced as the new President of NATHEALTH – an apex body representing the entire ecosystem of the Indian healthcare industry.

Dr Ashutosh Raghuvanshi steps in as new President of NATHEALTH Ameera Shah, Promoter & MD, Metropolis Healthcare elected as Senior Vice President

https://www.biospectrumindia.com/news/73/22839/oppi-reinforces-commitment-to-improving-health-outcomes-in-india.html

Speaking on the sidelines of the recently held mega event, the 14th National Conference of AIDS Society of India (ASICON), Dr Ishwar Gilada, President, AIDS Society of India (ASI) and Governing Council member of International AIDS Society (IAS), said, "Indian pharma's capacity to produce generic antiretrovirals and supply them globally had resulted in major successes for Acquired Immunodeficiency Syndrome (AIDS) fight worldwide as 92 per cent of Human Immuno-Deficiency Virus (HIV) medicines are from Indian pharma companies".

"We should immediately eliminate Mother to Child transmission of HIV": Dr Ishwar Gilada, President, ASI The AIDS Society of India (ASI) is a nation-wide network of HIV medical experts and researchers

World Health Organization has announced the expanded scope of the WHO Director-General’s (DG) Flagship Initiative on (TB) over the period from 2023 to 2027 to support fast-tracking progress towards ending TB and achieving Universal Health Coverage (UHC) by 2030.

WHO steps up Director-General’s flagship initiative to combat tuberculosis The initiative highlights the pressing need to increase both domestic and international investments in TB services, research, and innovation

Dr Mark Feinberg, President & CEO, IAVI (The International AIDS Vaccine Initiative), Rajat Goyal MD, Country Director, India, IAVI called on Union Minister of State (Independent Charge) Science & Technology Dr Jitendra Singh in New Delhi and urged for concrete proposals and guidance in developing sustainable for lasting source of livelihoods.

India calls for extended collaboration in biotech startups and vaccine development International AIDS Vaccine Initiative is partnering with India for the development of TB Vaccine

Nanoclean a New Delhi-based that is engineering advanced air filtration solutions, has launched Cigibud which is the world’s first Smoking Cessation Filter.

Nanoclean launches world’s first smoking cessation filter 'Cigibud' The product makes use of patented nanofiber technology directed at making the user accustomed to lower levels of ni****ne

Axio Biosolutions, a Bengaluru-based focused medtech company, has announced the US FDA 510(k) clearance for its latest innovation, AxSurgi Surgical Hemostat. With this, Ax-surgi has become the first and only chitosan based hemostat cleared for controlling severe surgical bleeding.

Axio Biosolutions announces US FDA clearance for Ax-Surgi Surgical Hemostat Ax-surgi is a ready to use, non-absorbable hemostat

MapAction has signed the Standby Partnership Agreement with the World Health Organization (WHO) which will allow the UK-based emergency response and disaster preparedness charity to have greater impact in health emergencies.

WHO signs partnership agreement with MapAction To have greater impact in health emergencies

Bengaluru-based Foundation for Neglected Disease Research (FNDR) and Spanish firm DevsHealth have announced the start of a collaborative project to develop new broad-spectrum antiviral agents for infections caused by flaviviruses such as dengue, Zika, West Nile virus, and Japanese encephalitis, among others.

Indo-Spanish collaboration to develop affordable drugs for mosquito-borne infections Foundation for Neglected Disease Research (India) and DevsHealth (Spain) announce a collaboration